Asia-Pacific TSM (Testing, Screening & Monitoring) Devices Market Outlook, 2028

The Asia Pacific region is home to a large and diverse population. The sheer size of the population, coupled with changing demographics and an aging population in some countries creates a substantial market for healthcare services, including testing, screening, and monitoring devices. The prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and respiratory conditions, is on the rise in the Asia Pacific region. This growing burden of chronic illnesses is driving the demand for TSM devices that enable early detection, continuous monitoring, and effective management of these conditions. Many countries in the Asia Pacific region are experiencing economic growth, leading to increased healthcare expenditure. As disposable incomes rise, individuals and healthcare institutions are more willing and able to invest in advanced healthcare technologies, including TSM devices. Several countries in the Asia Pacific region are focusing on strengthening their healthcare infrastructure through government initiatives and investments. This includes efforts to modernize healthcare facilities, improve access to medical services, and promote the adoption of innovative medical technologies, including TSM devices. There is a growing awareness of the importance of preventive healthcare and early detection of diseases in the Asia Pacific population. This awareness is driving the demand for TSM devices that empower individuals to monitor their health proactively and take preventive measures. Recent global health events, such as the COVID-19 pandemic, have underscored the importance of effective testing, screening, and monitoring for epidemic preparedness. This realization has led to increased investments in healthcare infrastructure and TSM devices to enhance the region's ability to respond to public health emergencies. Urbanization and changes in lifestyle patterns in the Asia Pacific region are associated with an increased risk of non-communicable diseases. TSM devices that enable continuous monitoring and early intervention are crucial in addressing the health challenges associated with urbanization and lifestyle changes.

According to the research report, "Asia Pacific Testing, Screening, and Monitoring (TSM) Market Outlook, 2028," published by Bonafide Research, the market is anticipated to grow at a 9% CAGR by 2023–28. The adoption of Remote Patient Monitoring (RPM) devices is increasing across the Asia Pacific region. RPM allows healthcare providers to monitor patients remotely, particularly beneficial in countries with large rural populations. This trend is supported by the growing prevalence of chronic diseases and the need for continuous patient care. Wearable devices, such as smartwatches and fitness trackers equipped with health monitoring features, are gaining popularity. These devices offer consumers the ability to track various health metrics, fostering a culture of self-monitoring and proactive health management. Artificial Intelligence (AI) and machine learning are being increasingly utilized in TSM Devices, particularly for diagnostic purposes. These technologies enhance the accuracy of diagnostics, support image analysis, and assist healthcare professionals in interpreting complex data sets. Mobile health applications, including those integrated with TSM Devices, are becoming increasingly popular. These applications facilitate health monitoring, medication adherence, and communication between patients and healthcare providers, contributing to improved healthcare management. Addressing healthcare disparities in rural areas is a key focus in several Asia Pacific countries. TSM Devices, especially those that support remote monitoring and diagnostics, play a crucial role in improving healthcare access for populations in remote or underserved regions. Some cities in the Asia Pacific region are exploring the integration of TSM Devices with smart city initiatives. This involves leveraging data from health monitoring devices to enhance public health services, urban planning, and emergency response systems.

The market is categorized into China, Japan, India, Australia and South Korea. In China, the TSM Devices market is thriving due to the country's rapid economic development, increasing healthcare investments, and a burgeoning middle-class population. The Chinese government's commitment to modernizing healthcare infrastructure, coupled with a focus on innovative technologies, has propelled the adoption of advanced TSM Devices. Notably, the market in China is witnessing a surge in wearable health technology, remote patient monitoring solutions, and AI-powered diagnostics. The large and aging population in China is driving demand for continuous health monitoring, especially for chronic disease management, creating a fertile ground for the expansion of TSM technologies. Similarly, in India, the TSM Devices market is experiencing significant growth fuelled by a combination of factors. India's commitment to achieving universal healthcare access, coupled with an increasing prevalence of chronic diseases, is driving the demand for TSM solutions. The country is witnessing a rise in point-of-care testing, telehealth adoption, and a focus on preventive healthcare. The Indian government's initiatives to promote digital health and the integration of TSM Devices in healthcare systems are contributing to the market's expansion. Additionally, the Indian market showcases a robust ecosystem of healthcare startups leveraging innovative technologies, further diversifying the TSM landscape.

In terms of product the market is categorized into Blood Glucose Monitor, Heart Rate Monitors, Multi Parameter Patient Monitoring Device, Drug Alcohol Screening Testing, ECG Devices and others. The Asia Pacific region has witnessed an increase in drug abuse and addiction-related issues. Governments and organizations are increasingly recognizing the need for effective screening and monitoring tools to address these concerns, driving the demand for drug screening devices. Many companies in the Asia Pacific region are emphasizing workplace safety and implementing drug screening programs to ensure a drug-free work environment. This has led to a growing demand for drug screening devices in occupational settings. Many organizations conduct pre-employment and periodic drug screening as part of their employee screening programs. The implementation of such programs, both in the public and private sectors, fuels the demand for drug screening devices. Drug screening is also vital in healthcare and rehabilitation settings, where monitoring for substance abuse is crucial for patient safety and effective treatment. The healthcare industry's focus on patient well-being and compliance adds to the demand for drug screening devices. The transportation industry, including aviation and logistics, often has strict safety regulations that mandate drug screening for employees involved in safety-sensitive roles. Compliance with these regulations contributes significantly to the demand for drug screening devices. Educational institutions, including schools and universities, may implement drug screening programs for students and staff to maintain a safe and drug-free learning environment. This extends the application of drug screening devices beyond workplaces.

Based on end user the market is categorized into Hospitals, Home and others. The Asia Pacific region has witnessed an increase in the prevalence of chronic diseases, such as diabetes and cardiovascular conditions. As individuals seek convenient ways to monitor their health, there is a growing demand for home testing, screening, and monitoring devices. The aging population in the Asia Pacific region has led to a higher incidence of age-related chronic conditions. Older individuals often prefer home-based monitoring solutions for their convenience, contributing to the growth of the Home segment in the TSM Devices market. Increasing awareness and a shift towards consumer-centric healthcare have empowered individuals to take an active role in managing their health. Home testing devices provide users with the ability to monitor their health parameters without the need for frequent visits to healthcare facilities. Busy lifestyles in urban areas of the Asia Pacific region make it challenging for individuals to visit healthcare facilities for routine testing. Home testing devices offer a convenient and time-saving solution for monitoring health conditions without disrupting daily routines. In terms of indications the market is segmented into Cardiovascular Disorders & Hypertension, Diabetes, Pregnancy, Respiratory Diseases, Cancer, Movement Disorders, Hearing Disorders, Wound Care and Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV). A trend of delayed childbirth, with women choosing to have children at older ages, has been observed. Advanced maternal age is associated with certain risks, making early and regular monitoring during pregnancy essential. This trend contributes to the demand for pregnancy-related testing devices. The Asia Pacific region experiences various pregnancy-related complications, including gestational diabetes, preeclampsia, and other conditions. Monitoring devices play a crucial role in the early detection and management of these complications, contributing to the growth of the market.



Companies covered in this report:

Abbott Laboratories , Koninklijke Philips N.V., Nihon Kohden Corporation, Siemens Healthineers, Mindray Medical International Limited, Medline Industries LP, Baxter International Inc., GE HealthCare Technologies, Inc., Omron Corporation, Beurer GmbH, Drägerwerk AG & Co. KGaA, Teledyne Technologies Incorporated

Considered in this report

• Geography: Asia Pacific
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• Asia pacific Testing, Screening, and Monitoring (TSM) market Outlook with its value and forecast along with its segments
• Country-wise Testing, Screening, and Monitoring (TSM) market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• China
• Japan
• India
• Australia
• South Korea

By Product:

• Blood Glucose Monitor
• Heart Rate Monitors
• Multiparameter Patient Monitoring
• Drug Screening
• Electrocardiograph (ECG)
• Others (Blood Pressure Monitoring Devices, Pulse Oximeter, Patient Temperature Monitoring, Fetal Monitoring Devices, Others)

By End User:

• Hospitals
• Home
• Others

By Indication:

• Cardiovascular Disorders & Hypertension
• Diabetes
• Pregnancy
• Respiratory Diseases
• Cancer
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Testing, Screening, and Monitoring (TSM) industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.